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in a truly serial fashion, the fate of jailed BVS side branch struts up to 5
years follow-up using a validated ‘cut-plane’; method. We showed
that initially the total surface of the jailed ostia decreased due to
closure of 1 or more compartments. However, after full bioresorption
of the scaffold, the surface of the compartments which remained
patent gradually increased from 2/3 years to 5 years. This information
might have important implications for future bifurcation treatment
using bioresorbable scaffolds.
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BACKGROUND Bioresorbable vascular scaffolds have emerged as an
alternative to permanent metallic device implants to treat vascular
restenosis, because they degrade over time leaving the remodeled
intimal layer with potential for full endothelial recovery. The devel-
opment of a suitable bioresorbable polymer has been challenging
because it must exhibit endothelial biocompatibility as the polymer
degrades down and releases the antiproliferative drug such that
complete vascular healing is achieved. The aims of this study were to
characterize endothelial biocompatibility of bioresorbable materials
and drugs using endothelial cell-based screening assays of apoptosis,
oxidative stress, prothrombotic mediators and autophagic processes.
METHODS Endothelial cell line EAHy926 were cultured in chamber
slides coated with poly-DL-lactide, (PDLA) 500 ug/cm2 and paclitaxel
3.125 ug/cm2 for seven days. Flow cytometric analysis was used to
measure cytotoxicity, apoptosis (Annexin V and 7-amino-actinomycin
D staining), expression of tissue factor, thrombomodulin, nitro-
tyrosine, cell adhesion molecules (CD31/PECAM-1, CD62E/E-selectin,
CD162/PSGL-1), activated protein C receptor (CD201), co-stimulation
modulators (CD154/CD40L, CD27/TNF receptor) and microtubule-
associated protein 1A/1B-light chain 3.
RESULTS Treatment of endothelial cells with PDLA and paclitaxel
induced increase in Annexin V expression, indicating enhanced
apoptosis. Paclitaxel alone and in combination with PDLA upregu-
lated tissue factor (by 37.8% vs control 12%) and down-regulated
thrombomodulin (86.8% vs control 98.5%). Endothelial cells incu-
bated in PDLA and paclitaxel showed marked increase in nitrotyrosine
expression (66.2% vs control 34.2%) and exhibited an apparent cell
death compared to the negative control. Paclitaxel alone or in com-
bination with PDLA showed up-regulation of microtubule-associated
protein 1A/1B-light chain 3 (44.6% vs control 13.8%), indicating acti-
vation of autophagy and impaired endothelial cell quality control.
PDLA and paclitaxel had no signiﬁcant effect on the expression of cell
adhesion molecules, activated protein C receptor, and co-stimulation
modulators.
CONCLUSIONS The results indicate that PDLA and paclitaxel promote
oxidative stress, enhance apoptosis and induce excessive stimulation
of autophagy, indicating that bulk hydrolysis of PDLA to lactic acid
leads to cytotoxicity and may suppress endothelial regeneration.CATEGORIES CORONARY: Stents: Bioresorbable Vascular Scaffolds
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BACKGROUND The aim of this study was to compare the acute
expansion behavior of a polymer based Bioresorbable Scaffold and a
second generation metallic DES platform in a coronary artery lesion
model. Although there are signiﬁcant differences in the material
properties between currently available metallic stents and polymer
based bioresorbable scaffolds, experimental data have shown so far
little differences in their mechanical properties. Still, differences in
acute results have been observed in clinical studies comparing BVS
directly to metallic DES platforms.
METHODS We examined the expansion behavior of the Bioresorbable
Vascular Scaffold (3.0x18mm Absorb BVS; Abbott Vascular, Santa
Clara, CA) and a metallic DES (3.0x18mm Xience Prime; Abbott
Vascular, Santa Clara, CA) after expansion at 37C in an identical
coronary artery stenosis model (12 different experiments were per-
formed in total). Devices expansions were compared during balloon
inﬂation and after deﬂation using microscopy to allow assessment of
plaque recoil. Minimal Lumen Diameter (MLD) and Minimal Lumen
Area (MLA) and Stent eccentricity were quantiﬁed from Optical
Coherence Tomography (OCT) imaging at nominal diameter and after
post-dilation at 18 ATM.
RESULTS The MLA in the models with BVS deployed was 4.92  0.17
while in the metallic DES was 5.40  0.13mm2(p¼0.02) at Nominal
Pressure (NP) and 5.41  0.20 and 6.07  0.25 mm2 (p¼0.02) after
expansion at 18 ATM respectively. Stent eccentricity index at the MLA
was 0.71  0.02 in BVS compared to 0.81  0.02 in the metal stent at
NP (p¼0.003), and 0.73  0.03 compared to 0.75  0.02 at 18 ATM.
CONCLUSIONS Such in-vitro experiments provide insights to better
understand the behavior of BVS scaffolds and to guide their optimal
implantation in-vivo.
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